Combined with the reduced expression of FoxO3 in the aging brain, our results support the concept that elevating astrocytic FoxO3 may reverse cortical astrogliosis and associated functional impairment in aging and Alzheimer's disease. This evidence concerns the gene FOXO3 and early-onset autosomal dominant Alzheimer disease.